热门资讯> 正文
艾伯维与Iambic Therapeutics达成多年人工智能药物发现协议
2026-09-21 20:09
- 艾伯维公司(ABBV) 0
- 摩根士丹利(MS) 0
- 富国银行(WFC) 0
- AbbVie (ABBV) and Iambic Therapeutics have entered a multi-year collaboration to discover and develop small-molecule therapies for immunology, neuroscience, and oncology using Iambic's AI discovery platform.
- The companies will leverage Iambic's AI platform to improve the efficiency and success of identifying promising new drug candidates.
- Under the terms of the collaboration, Iambic will receive an upfront payment and is eligible to receive success-based milestone payments and tiered royalties on net sales from products generated from the collaboration.
- The collaboration targets both first-in-class and best-in-class small molecule drug candidates.
- ABBV is down about 1% premarket.
More on AbbVie
- AbbVie Inc. (ABBV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- AbbVie Inc. (ABBV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
- AbbVie: Shares Defy Sell-Side Downgrades, And That's Bullish (Technical Analysis)
- Trump announces MFN pricing for Medicaid in all states
- AbbVie succeeds in late-stage trial for multiple myeloma drug
推荐文章
华盛早报 | 两大利好引爆芯片股！英特尔大涨12%，AMD市值破万亿美元；Muse智能体助推Meta飙升11%；阿里云栖大会今日开幕
美股前瞻 | 中美高层会谈释放积极信号！纳指期货升逾1%；比特币再度站上8.5万美元；英特尔盘前升逾5%，布局先进封装剑指光通信赛道
新股申购 | 四只新股今起招股！PCB龙头景旺电子、直驱机器人公司本末科技、罗博特科、彤程新材在列
港股异动 | 创新药概念集体走高，英派药业-B飙涨逾27%，荣昌生物、康方生物、信达生物涨逾6%，药明生物涨逾5%
华盛早报 | 中美经贸磋商正在纽约进行！特朗普引爆资源股！GLND夜盘飙升119%；景旺电子等四只新股今起招股
一周财经日历 | 特朗普将就美伊战争做出“重大决定”！美联储多位官员下周密集发声；纳指100季度调整将生效；港股中秋节正常交易
港股周报 | 加息落地！科技股企稳反弹，恒生科指涨近2%；利润率比肩戴尔？联想周涨20%再创新高
凯西・伍德：马斯克旗下SpaceX存在10万亿美元市场机遇
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
